Medicine & Life Sciences
Netherlands
100%
Systematic Reviews
75%
Child
53%
Cohort Studies
52%
Meta-Analysis
52%
Therapeutics
49%
Population
46%
Delivery of Health Care
44%
Randomized Controlled Trials
44%
Health
42%
Neoplasms
40%
Cost-Benefit Analysis
37%
Pandemics
35%
Costs and Cost Analysis
31%
SARS Virus
30%
Coronavirus
29%
Brain
29%
Quality of Life
28%
Survival
27%
Confidence Intervals
27%
Guidelines
26%
Mortality
25%
Mothers
24%
Registries
24%
Pregnancy
24%
Dementia
23%
Pediatrics
23%
Genes
23%
Mental Health
23%
Depression
23%
Biomarkers
22%
Prospective Studies
21%
Prostatic Neoplasms
20%
Observational Studies
20%
Mutation
20%
Safety
19%
Occupational Groups
19%
Caregivers
19%
Incidence
19%
Stroke
19%
Pain
19%
Multicenter Studies
19%
Psychology
18%
Motivation
18%
Pharmaceutical Preparations
18%
Colorectal Neoplasms
17%
Learning
17%
Infections
17%
Breast Neoplasms
16%
Cross-Sectional Studies
16%
Kidney
16%
Odds Ratio
16%
Early Detection of Cancer
16%
Equipment and Supplies
15%
Phenotype
15%
Nursing Homes
15%
Economics
15%
Decision Making
15%
Parents
15%
Datasets
15%
Magnetic Resonance Imaging
15%
Health Care Outcome Assessment
15%
Parenting
15%
Databases
15%
Education
14%
Genome
14%
Genome-Wide Association Study
14%
Longitudinal Studies
14%
Pharmacokinetics
14%
Anxiety
14%
Patient Reported Outcome Measures
14%
Exercise
14%
Technology
13%
Students
13%
Quality-Adjusted Life Years
13%
Recurrence
13%
Retrospective Studies
13%
Income
13%
Organoids
13%
Organizations
12%
Transplants
12%
Data Analysis
12%
Interviews
12%
Neoplasm Metastasis
12%
Primary Health Care
12%
Intellectual Disability
12%
Liver
12%
Wounds and Injuries
11%
Communication
11%
Low Back Pain
11%
Cognition
11%
Lung
11%
Logistic Models
11%
Research Personnel
11%
Growth
11%
DNA Methylation
11%
Clinical Trials
11%
Elderly
11%
Cardiovascular Diseases
11%
Osteoarthritis
11%
Social Sciences
Netherlands
62%
health
29%
evidence
25%
performance
24%
time
24%
economics
21%
employee
21%
governance
21%
happiness
21%
literature
20%
costs
20%
experiment
20%
leadership
19%
Healthcare
19%
EU
18%
adolescent
17%
management
16%
market
16%
Group
16%
experience
15%
firm
15%
innovation
15%
evaluation
15%
trend
14%
justice
14%
citizen
14%
migrant
13%
dementia
13%
leader
13%
well-being
13%
China
12%
learning
12%
worker
12%
interaction
12%
migration
12%
resources
12%
gender
12%
politics
11%
stakeholder
11%
European Union
11%
income
11%
cancer
11%
Law
11%
economy
11%
responsibility
10%
education
10%
mental health
10%
regulation
10%
health care
10%
follower
10%
quality of life
10%
taxes
10%
industry
10%
manager
9%
student
9%
decision making
9%
life years
9%
social media
9%
anxiety
9%
human being
9%
food
9%
cause
9%
discourse
9%
financial market
8%
determinants
8%
incentive
8%
climate
8%
resilience
8%
uncertainty
8%
organization
8%
Federal Republic of Germany
8%
communication
8%
emotion
8%
interview
8%
sustainability
8%
caregiver
8%
labor
8%
participation
8%
climate change
8%
event
8%
public administration
8%
demand
7%
expert
7%
narrative
7%
brain
7%
questionnaire
7%
methodology
7%
regression
7%
offense
7%
citizenship
7%
India
7%
personality
7%
globalization
7%
lack
7%
resident
6%
legitimacy
6%
autonomy
6%
mortality
6%
music
6%
childhood
6%
Business & Economics
Managers
22%
The Netherlands
21%
Innovation
21%
Performance
18%
Entrepreneurship
17%
Investors
17%
Economics
13%
Incentives
13%
Governance
11%
Entrepreneurs
11%
Marketing
10%
Sustainability
10%
United States of America
9%
Costs
9%
Alternatives
9%
Employees
9%
Equity
8%
Resources
8%
Decision Making
8%
Factors
8%
Multinational Enterprises (MNEs)
8%
Health
7%
Experiment
7%
Income
7%
Corporate Governance
7%
Empirical Evidence
7%
Industry
7%
Workers
7%
China
6%
Small and Medium-sized Enterprises (SMEs)
6%
Prediction
6%
Uncertainty
6%
Government
6%
Stock Market
6%
Standardization
6%
Testing
6%
Finance
6%
Stakeholders
6%
Chief Executive Officer
5%
Planning
5%
Healthcare
5%
Railway
5%
Economic Growth
5%
Predictors
5%
Value at Risk
5%
Modeling
5%
Interaction
5%
Meta-analysis
5%
Integrated
5%
Profit
5%
Literature Review
5%
Disclosure
5%
Team Performance
5%
Buyers
5%
Organisation for Economic Cooperation and Development
5%